Find verified Nimetazepam API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Nimetazepam for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Nimetazepam API.
Alternate Names: 1-Methylnitrazepam, Erimin, Methylnitrazepam
CAS No: 2011-67-8
PubChem CID: 4496
Mol Formula: C16H13N3O3
Mol Weight: 295.29 g/mol
Controlled Drug Substance: Yes (Schedule IV)
IUPAC Name: 1-methyl-7-nitro-5-phenyl-3H-1,4-benzodiazepin-2-one
Therapeutic use: Sleeping drugs
Drug Class: Benzodiazepines, Schedule IV controlled substances
Commercial / Development Status: Commercial APIs
Source / Manufacturing Origin: Synthetic APIs
API Description: Nimetazepam is a nitrazepam which is substituted at positions 1 by a methyl group. It is used as an anticonvulsant and as a hypnotic for the short-term management of insomnia. It has a role as an anticonvulsant, a sedative, a GABA modulator and an antispasmodic drug. It is a 1,4-benzodiazepinone and a C-nitro compound. It is functionally related to a nitrazepam. Nimetazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. Nimetazepam (marketed under brand name Erimin) is an intermediate-acting hypnotic drug which is a benzodiazepine derivative. It was first synthesized by a team at Hoffmann-La Roche in 1962.
